Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
OPERATING ACTIVITIES:
Net loss	$ (1,127,454)	$ (488,275)
Gain on derecognition of certain accounts payable and accrued expenses	(226,645)	375,271
Expenses paid directly by related party	665,497	206,022
Expenses paid directly by exercise of stock options and warrants		59,611
Loss on modification of stock options and warrants		115,722
Prepaid expenses	35,477
Accounts payable	(26,235)	(44,839)
Accrual for settlement of lawsuits	173,557	193,313
Accrued interest – related parties	506,997	321,471
Net cash provided by (used in) operating activities	1,164	(12,246)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash flows from investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of common stock options and warrants		11,500
Cash flows from financing activities		11,500
INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS	1,164	(746)
CASH AND CASH EQUIVALENTS, beginning of period	1,199	1,945
CASH AND CASH EQUIVALENTS, end of period	2,363	1,199
Non-Cash Investing and Financing:
Advances from related party used for settlement of liabilities	665,498	206,022
Expenses paid by exercise of common stock options and warrants		95,058
Expenses prepaid by exercise of common stock options and warrants		35,447
Related party promissory note settled by exercise of options